Efficacy and safety of long term entecavir in Chronic Hepatitis B NUC naive patients in real life

被引：0
|
作者：
Ridruejo, Ezequiel [1 ,2 ]
Marciano, Sebastian [3 ]
Galdame, Omar A. [3 ]
Virginia Reggiardo, Maria [4 ]
Munoz, Alberto [5 ]
Adrover, Raul [6 ]
Cocozzella, Daniel R. [6 ]
Fernandez, Nora C. [7 ]
Estepo, Claudio R. [8 ]
Mendizabal, Manuel [2 ]
Romero, Gustavo [5 ]
Levi, Diana [5 ]
Schroder, Teresa [8 ]
Paz, Silvia [8 ]
Fainboim, Hugo [8 ]
Mando, Oscar G. [1 ]
Gadano, Adrian [3 ]
Silva, Marcelo O. [2 ]
机构：
[1] Ctr Educ Med & Invest Clin Norberto Quirno CEMIC, Dept Med, Hepatol Sect, Buenos Aires, DF, Argentina
[2] Hosp Univ Austral, Hepatol & Liver Transplant Unit, Pilar, Argentina
[3] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[4] Hosp Prov Centenario Sanat Amer, Rosario, Santa Fe, Argentina
[5] Hosp Bomorino Udaondo, Buenos Aires, DF, Argentina
[6] Ctr Hepatol, La Plata, Buenos Aires, Argentina
[7] Hosp Britan, Buenos Aires, DF, Argentina
[8] Hosp Francisco J Muniz, Buenos Aires, DF, Argentina
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
901
引用
收藏
页码：636A / 636A
页数：1
相关论文
共 50 条
  • [21] ENTECAVIR EFFECTIVENESS IN NAIVE AND NUC EXPERIENCED PATIENTS: INTERIM ANALYSIS OF THE ENTAS COHORT STUDY OF PATIENTS WITH CHRONIC HEPATITIS B
    Porro, E.
    Di Leo, A.
    Marzano, A.
    Brancaccio, G.
    Maimone, S.
    Fasano, M.
    Grasso, A.
    Bronte, F.
    Fagiuoli, S.
    Santantoniol, T.
    Morisco, F.
    Petrelli, E., I
    Baroni, G. Svegliati
    Labbadia, G.
    Badia, L.
    Niro, G. A.
    Vinci, M.
    Montineri, A.
    Vinelli, F.
    Massari, M.
    Nosotti, L., I
    Galati, G.
    Missale, G.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E50 - E51
  • [22] The impact of cirrhosis on the efficacy and safety of entecavir for patients with chronic hepatitis B
    Huang, Rui
    Wang, Jian
    Zhao, Xiang-An
    Xia, Juan
    Wu, Chao
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (11) : 1314 - 1314
  • [23] Efficacy of Entecavir Treatment for up to 5 Years in Nucleos(t)ide-Naive Chronic Hepatitis B Patients in Real Life
    Luo, Jie
    Li, Xiangyong
    Wu, Yuankai
    Lin, Guoli
    Pang, Yihua
    Zhang, Xiao
    Ao, Yunlong
    Du, Zhan
    Zhao, Zhixin
    Chong, Yutian
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (04): : 427 - 433
  • [24] Safety and efficacy of vebicorvir administered with entecavir in treatment-naive patients with chronic hepatitis B virus infection
    Sulkowski, Mark S.
    Agarwal, Kosh
    Ma, Xiaoli
    Nguyen, Tuan T.
    Schiff, Eugene R.
    Hann, Hie-Won L.
    Dieterich, Douglas T.
    Nahass, Ronald G.
    Park, James S.
    Chan, Sing
    Han, Steven-Huy B.
    Gane, Edward J.
    Bennett, Michael
    Alves, Katia
    Evanchik, Marc
    Yan, Ran
    Huang, Qi
    Lopatin, Uri
    Colonno, Richard
    Ma, Julie
    Knox, Steven J.
    Stamm, Luisa M.
    Bonacini, Maurizio
    Jacobson, Ira M.
    Ayoub, Walid S.
    Weilert, Frank
    Ravendhran, Natarajan
    Ramji, Alnoor
    Kwo, Paul Yien
    Elkhashab, Magdy
    Hassanein, Tarek
    Bae, Ho S.
    Lalezari, Jacob P.
    Fung, Scott K.
    Yuen, Man-Fung
    JOURNAL OF HEPATOLOGY, 2022, 77 (05) : 1265 - 1275
  • [25] Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B
    Law, Siu-tong
    Lee, Ming Kai
    Li, Kin Kong
    Mok, Chun Keung
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (02) : 193 - 198
  • [26] Comparison of the long-term efficacy between tenofovir and entecavir in chronic hepatitis B patients
    Liu, Kecheng
    Peng, Peng
    Cai, Fuqing
    Huang, Jiean
    GUT, 2021, 70 (08) : 1599 - 1600
  • [27] Real life adherence of chronic hepatitis B patients to entecavir treatment
    van Vlerken, Lotte G.
    Arends, Pauline
    Lieveld, Faydra I.
    Arends, Joop E.
    Brouwer, Willem Pieter
    Siersema, Peter D.
    Janssen, Harry L.
    van Erpecum, Karel J.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (07) : 577 - 583
  • [28] Efficacy and Safety of Entecavir Treatment of Chronic Hepatitis B Patients in Real-world clinical Practice
    Tanwandee, Tawesak
    Charatcharoenwitthaya, Phunchai
    Chainuvati, Siwaporn
    Chotiyaputta, Watcharasak
    Nimanong, Supot
    HEPATOLOGY, 2013, 58 : 672A - 672A
  • [29] COMPARISON OF TREATMENT EFFICACY OF CLEVUDINE TO ENTECAVIR FOR ANTIVIRAL NAIVE CHRONIC HEPATITIS B PATIENTS
    Kim, S. B.
    Song, I. H.
    Lee, H. I.
    Yang, H. Y.
    Kim, A. N.
    Chae, H. B.
    Lee, S. H.
    Kim, H. S.
    Lee, T. H.
    Kang, Y. W.
    Lee, E. S.
    Kim, S. H.
    Lee, B. S.
    Lee, H. Y.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S291 - S291
  • [30] Long-term use of entecavir in nucleoside-naive Japanese patients with chronic hepatitis B infection
    Yokosuka, Osamu
    Takaguchi, Koichi
    Fujioka, Shinichi
    Shindo, Michiko
    Chayama, Kazuaki
    Kobashi, Haruhiko
    Hayashi, Norio
    Sato, Chifumi
    Kiyosawa, Kendo
    Tanikawa, Kyuichi
    Ishikawa, Hiroki
    Masaki, Nobuyuki
    Seriu, Taku
    Omata, Masao
    JOURNAL OF HEPATOLOGY, 2010, 52 (06) : 791 - 799
12345